Cryoport, Inc. (CYRX) |
| 14.62 0.24 (1.67%) 06-12 16:00 |
| Open: | 14.45 |
| High: | 14.67 |
| Low: | 14.3 |
| Volume: | 500,881 |
| Market Cap: | 737(M) |
| PE Ratio: | -16.24 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Integrated Freight & Logistics |
| Sector: | Industrials |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 16.73 |
| Resistance 1: | 15.16 |
| Pivot price: | 15.16 |
| Support 1: | 12.61 |
| Support 2: | 10.49 |
| 52w High: | 16.73 |
| 52w Low: | 6.16 |
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
| EPS | -0.900 |
| Book Value | 8.980 |
| PEG Ratio | 62.13 |
| Gross Profit | 1.713 |
| Profit Margin (%) | 43.59 |
| Operating Margin (%) | -20.08 |
| Return on Assets (ttm) | -2.5 |
| Return on Equity (ttm) | -8.2 |
Fri, 12 Jun 2026
Cryoport (CYRX) tech chief exercises 35,000 options and sells shares - Stock Titan
Thu, 11 Jun 2026
CryoPort, Inc. (CYRX) reports Q1 loss, tops revenue estimates - MSN
Thu, 11 Jun 2026
[144] Cryoport, Inc. SEC Filing - Stock Titan
Wed, 10 Jun 2026
Senior VP Robert Stefanovich Sold A Bunch Of Shares In Cryoport - simplywall.st
Tue, 09 Jun 2026
Cryoport (NASDAQ: CYRX) investors approve directors, pay and expanded equity plan - Stock Titan
Tue, 09 Jun 2026
Cryoport (CYRX) director Linda Baddour receives new stock and option grants - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |